NIH VideoCast - Anita Roberts Lecture - Advancing the Development of Effective Therapies for Children and Adults with Rare Tumors

Skip Navigation

Anita Roberts Lecture - Advancing the Development of Effective Therapies for Children and Adults with Rare Tumors

Loading... Loading video...

380 Views

Air date:	Thursday, November 3, 2022, 11:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 380 (313 Live, 67 On-demand)
Category:	Anita B. Roberts - Distinguished Women Scientists
Runtime:	01:12:08
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Anita Roberts Lecture 2022 The “Distinguished Women Scientists at NIH” lecture series highlights the outstanding research achievements of woman scientists in the NIH Intramural Research Program. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist. Dr. Widemann is the Chief of the Pediatric Oncology Branch at NCI where she oversees basic, translational, and clinical research programs for children and young adults with hematologic and solid malignancies. Her research has been focused on drug development and early clinical trials for children with refractory solid tumors or genetic tumor predisposition syndromes, in particular neurofibromatosis type 1 (NF1). Her findings resulted in the first approved medical therapy for children with NF1.

NLM Title:	Advancing the development of effective therapies for children and adults with rare tumors / Brigitte Widemann.
Author:	Widemann, Brigitte. NIH Women Scientist Advisors Committee,
Publisher:
Abstract:	(CIT): Anita Roberts Lecture 2022 The "Distinguished Women Scientists at NIH" lecture series highlights the outstanding research achievements of woman scientists in the NIH Intramural Research Program. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist. Dr. Widemann is the Chief of the Pediatric Oncology Branch at NCI where she oversees basic, translational, and clinical research programs for children and young adults with hematologic and solid malignancies. Her research has been focused on drug development and early clinical trials for children with refractory solid tumors or genetic tumor predisposition syndromes, in particular neurofibromatosis type 1 (NF1). Her findings resulted in the first approved medical therapy for children with NF1.
Subjects:	Neoplasms--therapy Rare Diseases--therapy Therapies, Investigational
Publication Types:	Lecture Webcast

NLM Classification:	QZ 266
NLM ID:	9918573275406676
CIT Live ID:	45832
Permanent link:	https://videocast.nih.gov/watch=45832

Related Videos...